Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Hyams

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Managed Care (Langhorne, Pa.)|December 20, 2008
Understanding tumor profiling and assessing treatmentDavid M Hyams
Managed Care (Langhorne, Pa.)|December 7, 2010
Clinical advances in treatment options and diagnostics: new tools in the management of breast cancer and colon cancerDavid M Hyams
Clinical & Experimental Metastasis|December 8, 2023
Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?Jonathan S Zager, David M Hyams
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 25, 2017
Adenocarcinoma of the appendix occurring in a patient treated with paclitaxel for locally advanced esophageal cancerConstantin A Dasanu, David M Hyams, Frank J Senatore
Journal of Surgical Oncology|December 15, 2018
Identification of risk in cutaneous melanoma patients: Prognostic and predictive markersDavid M Hyams, Robert W Cook, Antonio C Buzaid
Cureus|January 3, 2025
Neoadjuvant Cetuximab Leading to a Complete Pathologic Response in Locally Advanced Lip Squamous Cell CarcinomaRuba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2018
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?Constantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Future Oncology (London, England)|October 6, 2020
Integrating the melanoma 31-gene expression profile test with surgical oncology practice within national guideline and staging recommendationsDavid M Hyams, Kyle R Covington, Clare E Johnson, et al.
Dermatology Online Journal|March 14, 2019
Merkel cell carcinoma: long-term follow-up of a single institution series and clinical outcomes by immunological statusConstantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Journal of Drugs in Dermatology : JDD|June 2, 2021
Clinical Considerations for Integrating Gene Expression Profiling into Cutaneous Squamous Cell Carcinoma ManagementSarah T Arron, Travis W Blalock, J Michael Guenther, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Managed Care (Langhorne, Pa.)|December 20, 2008
Understanding tumor profiling and assessing treatmentDavid M Hyams
Managed Care (Langhorne, Pa.)|December 7, 2010
Clinical advances in treatment options and diagnostics: new tools in the management of breast cancer and colon cancerDavid M Hyams
Clinical & Experimental Metastasis|December 8, 2023
Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?Jonathan S Zager, David M Hyams
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 25, 2017
Adenocarcinoma of the appendix occurring in a patient treated with paclitaxel for locally advanced esophageal cancerConstantin A Dasanu, David M Hyams, Frank J Senatore
Journal of Surgical Oncology|December 15, 2018
Identification of risk in cutaneous melanoma patients: Prognostic and predictive markersDavid M Hyams, Robert W Cook, Antonio C Buzaid
Cureus|January 3, 2025
Neoadjuvant Cetuximab Leading to a Complete Pathologic Response in Locally Advanced Lip Squamous Cell CarcinomaRuba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2018
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?Constantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Future Oncology (London, England)|October 6, 2020
Integrating the melanoma 31-gene expression profile test with surgical oncology practice within national guideline and staging recommendationsDavid M Hyams, Kyle R Covington, Clare E Johnson, et al.
Dermatology Online Journal|March 14, 2019
Merkel cell carcinoma: long-term follow-up of a single institution series and clinical outcomes by immunological statusConstantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Journal of Drugs in Dermatology : JDD|June 2, 2021
Clinical Considerations for Integrating Gene Expression Profiling into Cutaneous Squamous Cell Carcinoma ManagementSarah T Arron, Travis W Blalock, J Michael Guenther, et al.
Pageof 2